Connection
David Caldwell to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications David Caldwell has written about Reverse Transcriptase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.760 |
|
|
|
-
Bourgeois A, Womack S, Newsom D, Caldwell D. A review of rilpivirine and elvitegravir resistance features and implications for treatment sequencing. HIV Clin. 2012; 24(4):12-5.
Score: 0.405
-
Elsayed RK, Caldwell DJ. Etravirine: A novel nonnucleoside reverse transcriptase inhibitor for managing human immunodeficiency virus infection. Am J Health Syst Pharm. 2010 Feb 01; 67(3):193-205.
Score: 0.355